Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Predicted Annual Growth Rate of the Drug And Gene Delivery Devices Market Over the Coming Decade?

The market for drug and gene delivery devices has shown robust growth in the past years. Predictions state it will increase from $0.61 billion in 2024 to $0.67 billion in 2025, displaying a compound annual growth rate (CAGR) of 9.0%. The historical growth can be accredited to the development of healthcare infrastructure, the broadening scope of personalized gene therapy programs, a greater emphasis on preventive healthcare, treatment for rare and orphan diseases, and a heightened public awareness regarding health and various treatment alternatives.

In the upcoming years, the market for drug and gene delivery devices is projected to experience substantial growth, reaching $0.93 billion in 2029 with a compound annual growth rate (CAGR) of 8.7%. The robust growth in the forecast period can be associated with the escalating occurrence of chronic diseases, surging requirements for personalized medicine, increasing cognizance and acceptance of gene therapy, the rising demand for non-invasive and minimally invasive operations, and the growing approval of direct-to-patient delivery models. Notable trends within the forecast period encompass progress in biotech and genetic engineering, technological evolution in drug delivery systems, growing investments in research and development activities, the invention of unique delivery platforms, and advancements in diagnostic technologies.

What Factors Are Propelling the Growth of the Drug And Gene Delivery Devices Market from 2025 to 2034?

The growth of the drug and gene delivery devices market is poised to be driven by the rising acceptance of gene therapy. Gene therapy, a medical procedure that involves the modification, removal or introduction of genetic material in a patient’s cells to treat or prevent disease, is seeing an increase in demand due to its ability to address the root causes of genetic disorders and chronic diseases, providing innovative treatment solutions where traditional therapies may not suffice. Drug and gene delivery devices play a critical role in gene therapy as they enable precise targeting and controlled release of therapeutic genes, thereby improving the effectiveness of the treatment. For example, the National Centre for Biotechnology Information, a US-based resource for the scientific research community, predicted in November 2023 that the number of patients receiving gene therapies would increase from 16,244 in 2020 to 94,696 in 2025. As a result, the growing acceptance of gene therapy is a key driver for the expansion of the drug and gene delivery devices market.

Explore Comprehensive Insights Into The Global Drug And Gene Delivery Devices Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19404&type=smp

What Are the Major Players Making an Impact in the Drug And Gene Delivery Devices Market’s Growth?

Major companies operating in the drug and gene delivery devices market are Merck & Co. Inc., AbbVie Inc., Bayer AG, AstraZeneca plc, Medtronic plc, Amgen Inc., Moderna Inc., Biogen Inc., Sarepta Therapeutics Inc., SCIEX, Halozyme Therapeutics Inc., ViiV Healthcare Limited, Uniqure NV, Cytokinetics Inc., Prothena Corporation plc, Intellia Therapeutics Inc., Voyager Therapeutics Inc., sfm medical devices GmbH, Inovio Pharmaceuticals Inc., GenSight Biologics S.A., CRISPR Therapeutics

Which Upcoming Trends Are Set to Influence the Drug And Gene Delivery Devices Market’s Path Forward?

Prominent businesses in the drug and gene delivery devices sector are concentrating on the advancement of cutting edge products like artificial intelligence (AI) technology to secure a market advantage. AI technology applicable to drug delivery embodies the use of AI tactics and computations to heighten the accuracy, efficiency, and effectiveness of drug delivery systems. To exemplify, in December 2023, Envoya Inc., an organization based in the US well-known for its development of polymer-based nanoparticles for targeted delivery, unveiled a pioneering gene therapy drug delivery platform. The platform, merging biopolymer-nanoparticles with AI, aims to tackle significant drawbacks present in current gene therapy technologies, such as viral vectors and lipid nanoparticles. It’s been designed to not just ensure safety but also to address issues related to limited payload capacities and tissue targeting that have been a challenge with existing gene therapy delivery technologies.

Secure Your Global Drug And Gene Delivery Devices Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/drug-and-gene-delivery-devices-global-market-report

How Are the Key Segments of the Drug And Gene Delivery Devices Market Driving Opportunities and Innovations?

The drug and gene delivery devicesmarket covered in this report is segmented –

1) By Vector: Viral, Non-viral

2) By Method: In Situ, Ex Vivo

3) By Route Of Administration: Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical

Subsegments:

1) By Viral: Adenovirus Vectors, Lentivirus Vectors, Adeno-Associated Virus (AAV) Vectors, Herpes Simplex Virus (HSV) Vectors, Retrovirus Vectors, Baculovirus Vectors, Vaccinia Virus Vectors, Sendai Virus Vectors

2) By Non-Viral: Lipid Nanoparticles (LNP), Polymeric Nanoparticles, Liposomes, Dendrimers, Naked DNA/RNA Delivery, Electroporation-Based Delivery Systems, Nanoparticle-Based Delivery Systems, Polymer Micelles And Hydrogels.

What Regions Are Steering Growth in the Drug And Gene Delivery Devices Sector?

North America was the largest region in the drug and gene delivery devices market in 2024. The regions covered in the drug and gene delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Drug And Gene Delivery Devices Market Classified and Defined in Market Analysis?

Drug and gene delivery devices are tools designed to transport pharmaceuticals or genetic material into the body for therapeutic purposes, enabling targeted treatment of diseases at the molecular level with enhanced precision and efficacy. These devices are crucial in advancing personalized medicine by ensuring controlled release and optimal delivery of therapeutic agents to specific cells or tissues, minimizing side effects, and maximizing treatment effectiveness.

Browse Through More Similar Reports By The Business Research Company:

Hematology Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/hematology-drug-global-market-report

Respiratory Diseases Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/respiratory-disease-drugs-global-market-report

Metabolic Disorders Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: